{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:40:23Z","timestamp":1792712423490,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-PhD2013-13"],"award-info":[{"award-number":["ARUK-PhD2013-13"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13024-016-0110-7","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T08:59:52Z","timestamp":1465549192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Synaptophysin depletion and intraneuronal A\u03b2 in organotypic hippocampal slice cultures from huAPP transgenic mice"],"prefix":"10.1186","volume":"11","author":[{"given":"Claire S.","family":"Harwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"key":"110_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","volume":"41","author":"T G\u00f3mez-Isla","year":"1997","unstructured":"G\u00f3mez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease. Ann Neurol. 1997;41:17\u201324.","journal-title":"Ann Neurol"},{"key":"110_CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ. Alzheimer\u2019s disease is a synaptic failure. Science. 2002;298:789\u201391.","journal-title":"Science"},{"key":"110_CR3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/138920207783769530","volume":"8","author":"PN Lacor","year":"2007","unstructured":"Lacor PN. Advances on the understanding of the origins of synaptic pathology in AD. Curr Genomics. 2007;8:486.","journal-title":"Curr Genomics"},{"key":"110_CR4","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer Disease. Cold Spring Harb Perspect Med. 2011;1:a006189.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"110_CR5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"L-F Lue","year":"1999","unstructured":"Lue L-F, Kuo Y-M, Roher AE, Brachova L, Shen Y, Sue L, et al. Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. Am J Pathol. 1999;155:853\u201362.","journal-title":"Am J Pathol"},{"issue":"2","key":"110_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-510X(87)90057-8","volume":"78","author":"C Davies","year":"1987","unstructured":"Davies C. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzhimer\u2019s Disease. J Neurol Sci. 1987;78(2):151\u201364.","journal-title":"J Neurol Sci"},{"key":"110_CR7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572\u201380.","journal-title":"Ann Neurol"},{"key":"110_CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","volume":"56","author":"E Masliah","year":"2001","unstructured":"Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW, et al. Altered expression of synaptic proteins occurs early during progression of Alzheimer\u2019s disease. Neurology. 2001;56:127\u20139.","journal-title":"Neurology"},{"key":"110_CR9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF01273157","volume":"103","author":"K Blennow","year":"1996","unstructured":"Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidsson P. Synaptic pathology in Alzheimer\u2019s disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J Neural Transm. 1996;103:603\u201318.","journal-title":"J Neural Transm"},{"key":"110_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(00)00285-9","volume":"175","author":"C-I Sze","year":"2000","unstructured":"Sze C-I, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer\u2019s disease brains. J Neurol Sci. 2000;175:81\u201390.","journal-title":"J Neurol Sci"},{"key":"110_CR11","first-page":"1047","volume":"24","author":"WG Honer","year":"2003","unstructured":"Honer WG. Pathology of presynaptic proteins in Alzheimer\u2019s disease: more than simple loss of terminals. Mol Cell Basis Synaptic Loss Dysfunct Alzheimers Dis. 2003;24:1047\u201362.","journal-title":"Mol Cell Basis Synaptic Loss Dysfunct Alzheimers Dis"},{"key":"110_CR12","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","volume":"96","author":"AY Hsia","year":"1999","unstructured":"Hsia AY, Masliah E, McConlogue L, Yu G-Q, Tatsuno G, Hu K, et al. Plaque-independent disruption of neural circuits in Alzheimer\u2019s disease mouse models. Proc Natl Acad Sci U S A. 1999;96:3228\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"110_CR13","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke L, Masliah E, Yu G-Q, Mallory M, Rockenstein EM, Tatsuno G, et al. High-level neuronal expression of A\u03b21\u201342 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 2000;20:4050\u20138.","journal-title":"J Neurosci"},{"key":"110_CR14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9440(10)62963-X","volume":"167","author":"BP Rutten","year":"2005","unstructured":"Rutten BP, Van der Kolk NM, Schafer S, van Zandvoort MA, Bayer TA, Steinbusch HW, et al. Age-Related Loss of Synaptophysin Immunoreactive Presynaptic Boutons within the Hippocampus of APP751 SL, PS1 M146L, and APP751 SL\/PS1 M146L Transgenic Mice. Am J Pathol. 2005;167:161\u201373.","journal-title":"Am J Pathol"},{"key":"110_CR15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/brain\/awn312","volume":"132","author":"R Adalbert","year":"2008","unstructured":"Adalbert R, Nogradi A, Babetto E, Janeckova L, Walker SA, Kerschensteiner M, et al. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain. 2008;132:402\u201316.","journal-title":"Brain"},{"key":"110_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(99)01698-4","volume":"840","author":"J Larson","year":"1999","unstructured":"Larson J, Lynch G, Games D, Seubert P. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 1999;840:23\u201335.","journal-title":"Brain Res"},{"key":"110_CR17","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1523\/JNEUROSCI.2610-10.2011","volume":"31","author":"OA Shipton","year":"2011","unstructured":"Shipton OA, Leitz JR, Dworzak J, Acton CEJ, Tunbridge EM, Denk F, et al. Tau protein is required for amyloid -induced impairment of Hippocampal long-term potentiation. J Neurosci. 2011;31:1688\u201392.","journal-title":"J Neurosci"},{"key":"110_CR18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","volume":"24","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, et al. Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis. 2006;24:516\u201324.","journal-title":"Neurobiol Dis"},{"key":"110_CR19","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature06616","volume":"451","author":"M Meyer-Luehmann","year":"2008","unstructured":"Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, et al. Rapid appearance and local toxicity of amyloid-\u03b2 plaques in a mouse model of Alzheimer\u2019s disease. Nature. 2008;451:720\u20134.","journal-title":"Nature"},{"key":"110_CR20","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1073\/pnas.1206171109","volume":"109","author":"MA Busche","year":"2012","unstructured":"Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, et al. Critical role of soluble amyloid- for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci. 2012;109:8740\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"110_CR21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11064-005-8829-5","volume":"30","author":"IE Holopainen","year":"2005","unstructured":"Holopainen IE. Organotypic Hippocampal slice cultures: a model system to study basic cellular and molecular mechanisms of neuronal cell death, neuroprotection, and synaptic plasticity. Neurochem Res. 2005;30:1521\u20138.","journal-title":"Neurochem Res"},{"key":"110_CR22","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1523\/JNEUROSCI.1633-03.2004","volume":"24","author":"Q Wang","year":"2004","unstructured":"Wang Q. Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid -Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5. J Neurosci. 2004;24:3370\u20138.","journal-title":"J Neurosci"},{"key":"110_CR23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ceca.2009.12.010","volume":"47","author":"E Alberdi","year":"2010","unstructured":"Alberdi E, S\u00e1nchez-G\u00f3mez MV, Cavaliere F, P\u00e9rez-Samart\u00edn A, Zugaza JL, Trullas R, et al. Amyloid \u03b2 oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium. 2010;47:264\u201372.","journal-title":"Cell Calcium"},{"key":"110_CR24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe DJ. Soluble oligomers of the amyloid \u03b2-protein impair synaptic plasticity and behavior. Behav Brain Res. 2008;192:106\u201313.","journal-title":"Behav Brain Res"},{"key":"110_CR25","doi-asserted-by":"crossref","first-page":"14624","DOI":"10.1038\/srep14624","volume":"5","author":"S Hellwig","year":"2015","unstructured":"Hellwig S, Masuch A, Nestel S, Katzmarski N, Meyer-Luehmann M, Biber K. Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-\u03b2 plaque formation in organotypic hippocampal slice cultures. Sci Rep. 2015;5:14624.","journal-title":"Sci Rep"},{"key":"110_CR26","doi-asserted-by":"crossref","unstructured":"Humpel C. Organotypic vibrosections from whole brain adult Alzheimer mice (overexpressing amyloid-precursor-protein with the Swedish-Dutch-Iowa mutations) as a model to study clearance of beta-amyloid plaques. Front. Aging Neurosci. 2015;7:47.","DOI":"10.3389\/fnagi.2015.00047"},{"key":"110_CR27","doi-asserted-by":"crossref","unstructured":"Golovyashkina N, Penazzi L, Ballatore C, Smith AB, Bakota L, Brandt R. Region-specific dendritic simplification induced by A\u03b2, mediated by tau via dysregulation of microtubule dynamics: a mechanistic distinct event from other neurodegenerative processes. Mol. Neurodegener. 2015;10:60.","DOI":"10.1186\/s13024-015-0049-0"},{"key":"110_CR28","doi-asserted-by":"crossref","first-page":"e608","DOI":"10.1038\/cddis.2013.129","volume":"4","author":"C Tackenberg","year":"2013","unstructured":"Tackenberg C, Grinschgl S, Trutzel A, Santuccione AC, Frey MC, Konietzko U, et al. NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss. Cell Death Dis. 2013;4:e608.","journal-title":"Cell Death Dis"},{"key":"110_CR29","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2007.04.014","volume":"29","author":"BP Tseng","year":"2008","unstructured":"Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM. A\u03b2 inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging. 2008;29:1607\u201318.","journal-title":"Neurobiol Aging"},{"key":"110_CR30","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1523\/JNEUROSCI.1879-05.2005","volume":"25","author":"TL Spires","year":"2005","unstructured":"Spires TL. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci. 2005;25:7278\u201387.","journal-title":"J Neurosci"},{"key":"110_CR31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","volume":"307","author":"GB Stokin","year":"2005","unstructured":"Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u2019s Disease. Science. 2005;307:1282\u20138.","journal-title":"Science"},{"key":"110_CR32","doi-asserted-by":"crossref","first-page":"21562","DOI":"10.1074\/jbc.M100710200","volume":"276","author":"MA Chishti","year":"2001","unstructured":"Chishti MA. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem. 2001;276:21562\u201370.","journal-title":"J Biol Chem"},{"key":"110_CR33","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nprot.2006.228","volume":"1","author":"A Simoni De","year":"2006","unstructured":"De Simoni A, Yu LM. Preparation of organotypic hippocampal slice cultures: interface method. Nat Protoc. 2006;1:1439\u201345.","journal-title":"Nat Protoc"},{"key":"110_CR34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nmeth1055","volume":"4","author":"T Misgeld","year":"2007","unstructured":"Misgeld T, Kerschensteiner M, Bareyre FM, Burgess RW, Lichtman JW. Imaging axonal transport of mitochondria in vivo. Nat Meth. 2007;4:559\u201361.","journal-title":"Nat Meth"},{"key":"110_CR35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Meth. 2012;9:676\u201382.","journal-title":"Nat Meth"},{"key":"110_CR36","doi-asserted-by":"crossref","unstructured":"Ippolito DM, Eroglu C. Quantifying Synapses: an Immunocytochemistry-based Assay to Quantify SynapseNumber. J. Vis. Exp. JoVE. 2010;2270.","DOI":"10.3791\/2270"},{"key":"110_CR37","doi-asserted-by":"crossref","unstructured":"Risher WC, Patel S, Kim IH, Uezu A, Bhagat S, Wilton DK, et al. Astrocytes refine cortical connectivity at dendritic spines. Luo L, editor. eLife. 2014;3:e04047.","DOI":"10.7554\/eLife.04047"},{"key":"110_CR38","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1523\/JNEUROSCI.4699-13.2014","volume":"34","author":"SU McKinstry","year":"2014","unstructured":"McKinstry SU, Karadeniz YB, Worthington AK, Hayrapetyan VY, Ozlu MI, Serafin-Molina K, et al. Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits. J Neurosci. 2014;34:9455\u201372.","journal-title":"J Neurosci"},{"key":"110_CR39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mrd.22489","volume":"82","author":"J Schindelin","year":"2015","unstructured":"Schindelin J, Rueden CT, Hiner MC, Eliceiri KW. The ImageJ ecosystem: An open platform for biomedical image analysis. Mol Reprod Dev. 2015;82:518\u201329.","journal-title":"Mol Reprod Dev"},{"key":"110_CR40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25\u00a0years of image analysis. Nat Meth. 2012;9:671\u20135.","journal-title":"Nat Meth"},{"key":"110_CR41","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1523\/JNEUROSCI.22-22-09785.2002","volume":"22","author":"O Lazarov","year":"2002","unstructured":"Lazarov O, Lee M, Peterson DA, Sisodia SS. Evidence that synaptically released \u03b2-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci. 2002;22:9785\u201393.","journal-title":"J Neurosci"},{"key":"110_CR42","doi-asserted-by":"crossref","first-page":"9794","DOI":"10.1523\/JNEUROSCI.22-22-09794.2002","volume":"22","author":"JG Sheng","year":"2002","unstructured":"Sheng JG, Price DL, Koliatsos VE. Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of A\u03b2 amyloidosis. J Neurosci. 2002;22:9794\u20139.","journal-title":"J Neurosci"},{"key":"110_CR43","doi-asserted-by":"crossref","unstructured":"Youmans KL, Tai LM, Kanekiyo T, Stine Jr WB, Michon S-C, Nwabuisi-Heath E, et al. Intraneuronal A\u03b2 detection in 5xFAD mice by a new A\u03b2-specific antibody. Mol. Neurodegener. 2012;7:1\u201314.","DOI":"10.1186\/1750-1326-7-8"},{"key":"110_CR44","unstructured":"Website: \u00a9 2015 Allen Institute for Brain Science. Allen Mouse Brain Atlas [Internet]. Available from: http:\/\/mouse.brain-map.org ."},{"key":"110_CR45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(92)90928-Z","volume":"138","author":"L Seress","year":"1992","unstructured":"Seress L, Guly\u00e1s AI, Freund TF. Pyramidal neurons are immunoreactive for calbindin D28k in the CA1 subfield of the human hippocampus. Neurosci Lett. 1992;138:257\u201360.","journal-title":"Neurosci Lett"},{"key":"110_CR46","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1523\/JNEUROSCI.01-11-01236.1981","volume":"1","author":"WD Knowles","year":"1981","unstructured":"Knowles WD, Schwartzkroin PA. Axonal ramifications of hippocampal Ca1 pyramidal cells. J Neurosci. 1981;1:1236\u201341.","journal-title":"J Neurosci"},{"key":"110_CR47","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1074\/jbc.274.13.8966","volume":"274","author":"L Zhang","year":"1999","unstructured":"Zhang L, Song L, Parker EM. Calpain Inhibitor I Increases \u03b2-Amyloid Peptide Production by Inhibiting the Degradation of the Substrate of \u03b3 -Secretase: evidence that substrate availability limits -amyloid peptide production. J Biol Chem. 1999;274:8966\u201372.","journal-title":"J Biol Chem"},{"key":"110_CR48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1750-1326-6-63","volume":"6","author":"RM Koffie","year":"2011","unstructured":"Koffie RM, Hyman BT, Spires-Jones TL. Alzheimer\u2019s disease: synapses gone cold. Mol Neurodegener. 2011;6:63.","journal-title":"Mol Neurodegener"},{"key":"110_CR49","doi-asserted-by":"crossref","first-page":"a005777","DOI":"10.1101\/cshperspect.a005777","volume":"4","author":"M Sheng","year":"2012","unstructured":"Sheng M, Sabatini BL, S\u00fcdhof TC. Synapses and Alzheimer\u2019s disease. Cold Spring Harb Perspect Biol. 2012;4:a005777.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"110_CR50","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1074\/jbc.M113.514992","volume":"289","author":"R Herrera-Molina","year":"2014","unstructured":"Herrera-Molina R, Sarto-Jackson I, Montenegro-Venegas C, Heine M, Smalla K-H, Seidenbecher CI, et al. Structure of Excitatory Synapses and GABAA Receptor Localization at Inhibitory Synapses Are Regulated by Neuroplastin-65. J Biol Chem. 2014;289:8973\u201388.","journal-title":"J Biol Chem"},{"key":"110_CR51","doi-asserted-by":"crossref","unstructured":"Sze C-I, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ. Loss of the Presynaptic Vesicle Protein Synaptophysin in Hippocampus Correlates with Cognitive Decline in Alzheimer Disease. J. Neuropathol. Exp. Neurol. 1997;56:933\u201344.","DOI":"10.1097\/00005072-199708000-00011"},{"key":"110_CR52","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1038\/srep07130","volume":"4","author":"D Yuki","year":"2014","unstructured":"Yuki D, Sugiura Y, Zaima N, Akatsu H, Takei S, Yao I, et al. DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer\u2019s disease. Sci Rep. 2014;4:7130.","journal-title":"Sci Rep"},{"key":"110_CR53","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.neurobiolaging.2005.04.008","volume":"27","author":"S Love","year":"2006","unstructured":"Love S, Siew LK, Dawbarn D, Wilcock GK, Ben-Shlomo Y, Allen SJ. Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol Aging. 2006;27:797\u2013803.","journal-title":"Neurobiol Aging"},{"key":"110_CR54","doi-asserted-by":"crossref","unstructured":"Trujillo-Estrada L, D\u00e1vila JC, S\u00e1nchez-Mejias E, S\u00e1nchez-Varo R, Gomez-Arboledas A, Vizuete M, et al. Early Neuronal Loss and Axonal\/Presynaptic Damage is Associated with Accelerated Amyloid-\u03b2 Accumulation in A\u03b2PP\/PS1 Alzheimer\u2019s Disease Mice Subiculum. J. Alzheimers Dis. 2014;42:521\u201341.","DOI":"10.3233\/JAD-140495"},{"key":"110_CR55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0165-3806(93)90109-N","volume":"71","author":"D Muller","year":"1993","unstructured":"Muller D, Buchs P-A, Stoppini L. Time course of synaptic development in hippocampal organotypic cultures. Dev Brain Res. 1993;71:93\u2013100.","journal-title":"Dev Brain Res"},{"key":"110_CR56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.nbd.2005.02.008","volume":"20","author":"CG Almeida","year":"2005","unstructured":"Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, Snyder EM, et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis. 2005;20:187\u201398.","journal-title":"Neurobiol Dis"},{"key":"110_CR57","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","volume":"26","author":"C Priller","year":"2006","unstructured":"Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J. Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein. J Neurosci. 2006;26:7212\u201321.","journal-title":"J Neurosci"},{"key":"110_CR58","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0002-9440(10)64463-X","volume":"161","author":"RH Takahashi","year":"2002","unstructured":"Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, et al. Intraneuronal Alzheimer A\u03b242 Accumulates in Multivesicular Bodies and Is Associated with Synaptic Pathology. Am J Pathol. 2002;161:1869\u201379.","journal-title":"Am J Pathol"},{"key":"110_CR59","doi-asserted-by":"crossref","first-page":"9704","DOI":"10.1523\/JNEUROSCI.2292-09.2009","volume":"29","author":"D Tampellini","year":"2009","unstructured":"Tampellini D, Rahman N, Gallo EF, Huang Z, Dumont M, Capetillo-Zarate E, et al. Synaptic Activity Reduces Intraneuronal A, Promotes APP Transport to Synapses, and Protects against A -Related Synaptic Alterations. J Neurosci. 2009;29:9704\u201313.","journal-title":"J Neurosci"},{"key":"110_CR60","doi-asserted-by":"crossref","unstructured":"Christensen DZ, Huettenrauch M, Mitkovski M, Pradier L, Wirths O. Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal A\u03b2 accumulation. Front. Aging Neurosci. 2014;6:139","DOI":"10.3389\/fnagi.2014.00139"},{"key":"110_CR61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1601-183X.2007.00372.x","volume":"7","author":"TA Bayer","year":"2008","unstructured":"Bayer TA, Wirths O. Review on the APP\/PS1KI mouse model: intraneuronal A\u03b2 accumulation triggers axonopathy, neuron loss and working memory impairment. Genes Brain Behav. 2008;7:6\u201311.","journal-title":"Genes Brain Behav"},{"key":"110_CR62","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-013-1107-8","volume":"125","author":"S Kumar","year":"2013","unstructured":"Kumar S, Wirths O, Theil S, Gerth J, Bayer TA, Walter J. Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer\u2019s disease. Acta Neuropathol (Berl). 2013;125:699\u2013709.","journal-title":"Acta Neuropathol (Berl)"},{"key":"110_CR63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1750-3639.2002.tb00442.x","volume":"12","author":"O Wirths","year":"2002","unstructured":"Wirths O, Multhaup G, Czech C, Feldmann N, Blanchard V, Tremp G, et al. Intraneuronal APP\/A\u03b2 Trafficking and Plaque Formation in \u03b2-Amyloid Precursor Protein and Presenilin-1 Transgenic Mice. Brain Pathol. 2002;12:275\u201386.","journal-title":"Brain Pathol"},{"key":"110_CR64","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/brain\/awq341","volume":"134","author":"D-S Yang","year":"2011","unstructured":"Yang D-S, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, et al. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer\u2019s disease ameliorates amyloid pathologies and memory deficits. Brain. 2011;134:258\u201377.","journal-title":"Brain"},{"key":"110_CR65","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3171\/jns.2003.98.5.1072","volume":"98","author":"DH Smith","year":"2003","unstructured":"Smith DH, Chen X, Iwata A, Graham DI. Amyloid \u03b2 accumulation in axons after traumatic brain injury in humans. J Neurosurg. 2003;98:1072\u20137.","journal-title":"J Neurosurg"},{"key":"110_CR66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0002-9440(10)63303-2","volume":"165","author":"X-H Chen","year":"2004","unstructured":"Chen X-H, Siman R, Iwata A, Meaney DF, Trojanowski JQ, Smith DH. Long-term accumulation of amyloid-\u03b2, \u03b2-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am J Pathol. 2004;165:357\u201371.","journal-title":"Am J Pathol"},{"key":"110_CR67","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/jnen\/61.12.1056","volume":"61","author":"A Iwata","year":"2002","unstructured":"Iwata A, Chen X-H, McIntosh TK, Browne KD, Smith DH. Long-Term Accumulation of Amyloid-\u03b2 in Axons Following Brain Trauma Without Persistent Upregulation of Amyloid Precursor Protein Genes. J Neuropathol Exp Neurol. 2002;61:1056\u201368.","journal-title":"J Neuropathol Exp Neurol"},{"key":"110_CR68","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/157015907780077105","volume":"5","author":"S Cho","year":"2007","unstructured":"Cho S, Wood A, Bowlby MR. Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics. Curr Neuropharmacol. 2007;5:19.","journal-title":"Curr Neuropharmacol"},{"key":"110_CR69","first-page":"127984","volume":"2011","author":"A Mohamed","year":"2011","unstructured":"Mohamed A, Posse de Chaves E. A\u03b2 Internalization by Neurons and Glia. Int J Alzheimers Dis. 2011;2011:127984.","journal-title":"Int J Alzheimers Dis"},{"key":"110_CR70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1096-9861(19980720)397:1<139::AID-CNE10>3.3.CO;2-7","volume":"397","author":"BA Bahr","year":"1998","unstructured":"Bahr BA, Hoffman KB, Yang AJ, Hess US, Glabe CG, Lynch G. Amyloid \u03b2 protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J Comp Neurol. 1998;397:139\u201347.","journal-title":"J Comp Neurol"},{"key":"110_CR71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","volume":"156","author":"GK Gouras","year":"2000","unstructured":"Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, et al. Intraneuronal A\u03b242 Accumulation in Human Brain. Am J Pathol. 2000;156:15\u201320.","journal-title":"Am J Pathol"},{"key":"110_CR72","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","volume":"8","author":"FM LaFerla","year":"2007","unstructured":"LaFerla FM, Green KN, Oddo S. Intracellular amyloid-\u03b2 in Alzheimer\u2019s disease. Nat Rev Neurosci. 2007;8:499\u2013509.","journal-title":"Nat Rev Neurosci"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-016-0110-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T10:16:54Z","timestamp":1568024214000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-016-0110-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["110"],"URL":"https:\/\/doi.org\/10.1186\/s13024-016-0110-7","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]},"article-number":"44"}}